Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Adenoviridae Infections × Interferon-beta × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Ovarian Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Carcinoma, Ovarian Epithelial 1 Brain Neoplasms 1 Astrocytoma 1 Adenoviridae Infections 1

Interventions

Cell Count 2 tretazicar 1 fludarabine 1 enadenotucirev 1 Vaccines 1 Tumor Necrosis Factor-alpha 1 Radiotherapy 1 Interferon-beta 1 Genetic Engineering 1 Endostatins 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00031083 2020-11-17

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Biogen

Phase 1 Completed

Adenoviridae Infections, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡